Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression
- PMID: 32463329
- DOI: 10.1177/1352458520926459
Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources